|
|
|
|
SurModics Announces Changes to Its Organizational Structure and Cost-Cutting Initiatives
SurModics, Inc.(Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, today announced changes designed to improve the Companys ability to meet the growing needs of its...
|
|
|
Cardiovascular Systems Inc. - Cardiovascular Systems Signs Merger Agreement
(CSI) announced that it has entered into a definitive merger agreement under which CSI will merge with Replidyne, Inc.(Nasdaq: RDYN) in an all-stock transaction. Cardiovascular Systems Inc. - Cardiovascular Systems Signs...
|
|
|
Replidyne, Inc. - Replidyne and Cardiovascular Systems Sign Merger Agreement
Replidyne, Inc.(NASDAQ:RDYN) and Cardiovascular Systems, Inc. (CSI) announced that they have entered into a definitive merger agreement under which CSI will merge with Replidyne in an all-stock transaction. Replidyne, Inc. -...
|
|
|
Study compares survival following different heart disease treatments in patients with ESRD
- (NewsRx.com) -- For patients with end stage renal disease (ESRD) on dialysis who also must be treated for heart disease, stents provide the best one-year survival compared with other revascularization treatments, but bypass surgery...
|
|
|
WaveMark and LUMEDX Partner to Provide Integrated RFID-Enabled Solution to Streamline the Healthcare Supply Ch
WaveMark, Inc., a leading provider of real-time inventory management (RTIM) solutions for high value medical products, and LUMEDX, the market leader in developing end'to-end cardiovascular information and imaging systems, today...
|
|
|
FDA: New Data On Takeda Gout Drug OK On Heart Risks
WASHINGTON -(Dow Jones)- A new study of a proposed drug by Takeda Pharmaceutical Co.(4502. TO) designed to treat gout didn't show an increase in cardiovascular events that was seen in previous studies, the Food and Drug...
|
|
|
Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis invo
Of 20 randomized clinical trials, 19 trials pooled (63,899 pts) for all-cause mortality Pooled data showed relative risk (RR) of 0.93 Cardiovascular deaths assessed in 18 trials (59,469 pts) Major cardiovascular events assessed...
|
|
|
Declining kidney function increases mortality risk in the elderly
MedWire News: Rapid decline in kidney function is associated with increased risk for cardiovascular and all-cause mortality in older adults, research shows.Chronic kidney disease (CKD), which affects approximately 17% of the adult...
|
|
|
TZDs in Combination With Incretins: Synergy in Diabetes Treatment
UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 (UKPDS 33). Lancet 1998;352:837853.
|
|
|
Low-Dose Aspirin Did Not Reduce Cardiovascular Events in Patients with Type 2 Diabetes - Except in Those Over
Aspirin therapy is commonly used for primary prevention of cardiovascular events in persons with type 2 diabetes, but a Japanese study of 2,539 subjects found no statistically significant reduction in the primary end point of total...
|
|
|
Thomson Reuters Announces 100 Top Hospitals(R) for Cardiovascular Care
ANN ARBOR, Mich., Nov.17 /PRNewswire/ -- The Healthcare business of Thomson Reuters today released its annual study identifying the 100 U.S. hospitals that are setting the nation's benchmarks for cardiovascular care. The study -...
|
|
|
Safety fears over high-dose simvastatin spark generic targets row
A row over the Governments drive to increase use of generic simvastatin has blown up after the release of findings from a UK trial linking use of 80mg simvastatin to a 180% increase in risk of myopapthy and big jump in cases of...
|
|
|
Short Sleep Duration Linked to Cardiovascular Risk in Patients With Hypertension
CME News Author: Laurie Barclay, MD CME Author: Penny Murata, MD Release Date: November 14, Valid for credit through November 14, 2009 Credits Available Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)" for physicians;Family...
|
|
|
Reduction in Recurrent Cardiovascular Events With Prasugrel Compared With Clopidogrel in Patients With Acute C
Aims: In the TRITON-TIMI 38 trial, greater platelet inhibition with prasugrel reduced the first occurrence of the primary endpoint (cardiovascular death, MI, or stroke) compared with clopidogrel in patients with an acute coronary...
|
|
|
Hydromer, Inc. Enters Chinese Market
Hydromer, Inc.(OTCBB: HYDI) announces that it has entered into a Sales Representation Agreement with HnG Medical Incorporated to represent Hydromer medical coatings in the People's Republic of China. Under the terms of this relationship...
|
|
|
Heart Disease Patients May Not Benefit From Depression Screening
Results of a new study call into question recent clinical guidelines issued by leading cardiovascular groups, including the American Heart Association, which recommend patients with cardiovascular disease be screened for signs of...
|
|
|
Pharmacodynamic Evaluation of the Cardiovascular Effects Following the Coadministration of Cocaine and Ethanol
One of the most common drug dependencies occurring with alcoholism is cocaine dependence.This combination is particularly worrisome because of the increased risk of cardiovascular events associated with their co-abuse. Though it's...
|
|
|
TopAbstracts in Congestive Heart Failure 11/13/2008
Recent news - Congestive Heart Failure New Blood Test Predicts 90-Day Mortality in Heart Failure Patients: Presented at AHA- (DGDispatch) Irbesartan Ineffective in Treating Heart Failure With Preserved Ejection Fraction: Presented at AHA- ...
|
|
|
Patients With Cardiovascular Disease May Not Benefit From Depression Screening
my personal edition> cardiology other > news E-Mail this DGNews to a colleague DGNews PHILADELPHIA -- November 14, 2008 -- Results of a new study call into question recent clinical guidelines issued by leading cardiovascular...
|
|
|
NIH: Simple Blood Test Predicts Cardiovascular Disease Risk, Guides Treatment
-- New results from 3 studies presented at the 2008 American Heart Association (AHA) Scientific Sessions and published in scientific journals provide the strongest evidence to date that a simple blood test for high-sensitivity C-reactive...
|
|
|
Dialysis Patients Have Better Long-Term Survival With Coronary Bypass Than Stents: Presented at ASN
-- Although use of drug-eluting stents in dialysis patients is associated with the best 1-year survival, long-term survival is better in patients receiving coronary artery bypass graft (CABG) surgery and the survival advantage of surgery is...
|
|
|
NIH: Simple Blood Test Predicts Cardiovascular Disease Risk, Guides Treatment
-- New results from 3 studies presented at the 2008 American Heart Association (AHA) Scientific Sessions and published in scientific journals provide the strongest evidence to date that a simple blood test for high-sensitivity C-reactive...
|
|
|
Dialysis Patients Have Better Long-Term Survival With Coronary Bypass Than Stents: Presented at ASN
-- Although use of drug-eluting stents in dialysis patients is associated with the best 1-year survival, long-term survival is better in patients receiving coronary artery bypass graft (CABG) surgery and the survival advantage of surgery is...
|
|
|
[NEWS] CARDIOVASCULAR HEALTH: Statin Therapy Reduces Disease in Healthy Volunteers--But How, Exactly?
CARDIOVASCULAR HEALTH: Statin Therapy Reduces Disease in Healthy Volunteers-...Couzin Science 14 November 2008: 1039 DOI: 10.1126/science.322.5904.1039 Need? How Do I Get Access? Registered Users and rs User Name: Password: Auto...
|
|
|
Vest Monitors 'Individual' Air Pollution
WEDNESDAY, Nov.12 (HealthDay News) -- Scientists have used the novel idea of a 'pollution vest' to determine that individual exposure to air pollution can harm a person's heart health beyond whatever damage that community-level exposure...
|
